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330 The Journal of Thoracic and CardioBackground: Renal dysfunction is a prognostic marker in patients with cardiovas-
cular disease. However, no long-term follow-up studies on the influence of mild
renal dysfunction on mortality in patients undergoing coronary bypass grafting have
been reported. Therefore, we aimed to identify the significance of preoperative
(mild) renal dysfunction as a long-term predictor of clinical outcome after coronary
bypass surgery.
Methods: In 358 patients who underwent isolated saphenous vein aorta–coronary
artery bypass grafting, estimated glomerular filtration rates were calculated with the
Cockroft-Gault equation (GFRc). Patients were categorized into 2 groups (group 1,
GFRc71.1 mL · min1 · 1.73 m2; group 2, GFRc71.1 mL · min1 · 1.73 m2).
Multivariate Cox proportional hazard analyses were performed to determine the
independent prognostic value of GFRc.
Results: During a median follow-up of 18.2 years, 233 patients (65.1%) died.
Patients who died had lower GFRc and were older. Multivariate analysis demon-
strated that total mortality in patients with lower GFRc was significantly increased
(lower GFRc group vs normal GFRc group: hazard ratio, 1.44; P .019). Lower GFRc
was also an independent predictor of cardiac mortality (hazard ratio, 1.51; P .032). No
significant differences were observed between groups in the occurrence of myocardial
infarction and the need for reintervention.
Conclusions: Our study demonstrates that after long-term follow-up, preoperative
mild renal dysfunction is an independent predictor of long-term (cardiac) mortality
in patients who undergo coronary artery bypass grafting.
Several prognostic risk markers for mortality, reintervention, and theoccurrence of cardiac events after coronary bypass surgery have beenidentified over the last 2 decades. We have already demonstrated thatage and left ventricular function are continuous incremental riskfactors for mortality. Left ventricular function and completeness ofrevascularization are independent predictors of cardiac death, and age
and vessel disease are independent predictors of reintervention. Preoperative risk
markers for cardiac events are hypertension, diabetes mellitus, hypertriglyceride-
mia, obesity, and smoking.1
Patients with chronic renal failure are known to have an increased risk of
cardiovascular disease.2,3 In addition, outcome after coronary bypass surgery of
vascular Surgery ● February 2005
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CDpatients with end-stage renal disease is poor, and in this
group a 5-year survival of less than 50% has been ob-
served.4 Anderson and colleagues5 demonstrated that pa-
tients with mild renal dysfunction are predisposed to
adverse 30-day outcomes after coronary artery bypass
surgery. However, no studies assessed the influence of
mild preoperative kidney dysfunction on long-term out-
come after coronary bypass surgery. Therefore, we aimed
to identify the significance of renal function as a predic-
tor of long-term clinical outcome after coronary bypass
Table 1. Baseline characteristics of both groups at time o
Group 1 (n  215, GFR >
min1 · 1.73 m2
Mean age (y) 49.7 6.5
Sex
Male 96.3%
Female 3.7%
BMI (kg/m2) 24.1 1.5
Serum creatinine (mmol/mL) 97.2 11.1
GFRc (mL · min1 · 1.73 m2) 85.1 11.0
Diabetes mellitus
Yes 98.6%
No 1.4%
Smoking
Yes 41.9%
No 57.7%
Unknown 0.4%
Cholesterol (mmol/L) 7.61 1.42
Triglycerides (mmol/L) 1.70 1.01
BP systolic (mm Hg) 129 12
BP diastolic (mm Hg) 85 11
Angina pectoris CCS class
I 3.3%
II 45.6%
III 37.7%
IV 13.5%
Family history
Positive 9.3%
Negative 79.1%
Unknown 11.6%
LV function (CASS-WMS score)
5-7 64.2%
8-10 19.1%
10 16.7%
One-vessel disease 16.3%
Two-vessel-disease 38.1%
Three-vessel-disease (50% stenosis) 45.6%
Extracorporeal circulation time (min) 111 49
Data are mean  SD. BMI, Body mass index; GFRc, glomerular filtration
Canadian Cardiovascular Society; CASS, Coronary Artery Surgery Study;
*t Test.
†2-test.
‡Mann-Whitney test.surgery.
The Journal of ThoraciMethods
Patients
The clinical and angiographic definitions, as well as the surgical
technique and patient characteristics, have been previously de-
scribed in detail.6 Between April 1, 1976, and April 1, 1977, a
series of 446 consecutive patients underwent isolated saphenous
vein aorta-coronary bypass surgery in our hospital. Thirteen pa-
tients died within 30 days after surgery, and they were excluded
from this analysis. Another 18 patients in whom the revascular-
ization was combined with valve replacement surgery were also
rgery
L · Group 2 (n  143, GFR <70.1 mL ·
min1 · 1.73 m2) Significance (2-tailed)
57.2 6.0 .001*
78.3% .001†
21.7%
23.1 1.7 .001*
109.0 18.1 .001*
60.8 7.9 .001*
96.5% .274†
3.5%
35.0%
65.0% .186†
0.0%
7.60 1.37 .939*
1.70 1.30 .968*
132 12 .007*
84  8 .602*
.001†
0.7%
30.8%
44.1%
24.5%
7.0%
76.9% .561†
16.1%
62.9%
21.0% .904†
16.1%
9.1%
36.4% .034†
54.5%
115 49 .695‡
GFR) according to the Cockroft-Gault equation; BP, blood pressure; CCS,
, wall motion score; LV, left ventricular.f su
70.1 m
)
rate (
WMSexcluded. Of the remaining 415 patients, in 57 (13.7%), the esti-
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CDmated glomerular filtration rates according to the Cockroft-Gault
equation (GFRc) could not be calculated. This group was excluded
as well. Therefore, this study population consisted of 358 patients.
Several follow-up methods were used simultaneously to provide
the most complete information possible. All patients were fol-
lowed by using the anniversary method at our outpatient clinic or
the outpatient clinic of referring cardiologists.
Measurement of Serum Creatinine
Serum creatinine was measured with standard techniques in the
clinical chemistry laboratory of our institution from blood samples
drawn the week before surgery. Serum creatinine then was used to
calculate GFRc by using the Cockcroft-Gault equation [(140age
in years )  (weight in kg)]/(72  serum creatinine in mg/dL),
multiplied by 0.85 in women. This equation is closely correlated
with measured creatinine clearance (correlation coefficient, 0.83)
and gives a more accurate assessment of renal function than serum
creatinine alone.7
Statistical Analysis
In our analysis we categorized GFRc into quintiles, and the hazard
ratios were calculated for the lower GFRc quintiles compared with
the (reference) highest GFRc group. Univariate Cox proportional
hazard analysis demonstrated that the lowest 2 quintiles and the
highest 3 quintiles showed similar hazard ratios. Subsequently, the
patients were categorized into 2 groups (group 1: GFRc71.1 mL
· min1 · 1.73 m2, quintiles 3, 4, and 5; group 2: GFRc71.1 mL
· min1 · 1.73 m2, quintiles 1 and 2). Age was dichotomized in
a similar manner; this resulted in 2 groups with a cutoff point of
54.7 years.
To identify prognostic covariates that might have been re-
sponsible for a difference in survival time between groups,
survival curves were estimated by the method described by
Kaplan and Meier from the following variables: presence of left
main vessel disease, left ventricular function, number of vessels
involved, completeness of revascularization, preoperative dia-
Figure 1. All-cause mortality after coronary artery bypa
clearance: group 1, cGFR greater than 70.1 mL · min1 ·betes mellitus, preoperative cholesterol, number of distal anas-
332 The Journal of Thoracic and Cardiovascular Surgery ● Febrtomoses, preoperative smoking behavior, and hypertension. The
log-rank test was used to calculate the statistical significance of
differences in survival curves between groups. All variables
with a significance level of P  .10 in this univariate test were
included in a multivariate model proposed by Cox. The clinical
events studied were overall mortality, cardiac mortality, acute
myocardial infarction, and reintervention. Cardiac death was
defined as death from a documented cardiac cause or death from
an unknown cause. End points were scored in an hierarchical
manner.8 All statistical analyses were performed with SPSS
software (version 11.0; SPSS Inc, Chicago, Ill), and all reported
P values are 2 sided.
Results
Baseline Characteristics
The mean age of the entire study population was 52.6 years
(range, 20-74 years; SD, 7.35 years), and 10.9% were
women. The mean (SD) serum creatinine concentration in
the 2 GFRc groups was 97.2 mol/L (11.1 mol/L) and
109.0 mol/L (18.1 mol/L), respectively. Only 3 patients
had a GFRc40 mL · min1 · 1.73 m2 (minimum, 32.1 mL
· min1 · 1.73 m2). The mean GFRc of both groups was
within 2 SD of normal GFR values in the general population.9
Other baseline clinical characteristics are shown in Table 1.
Thirty-day operative mortality for the study population was
2.9%. Only 1 patient was lost to follow-up. The median dura-
tion of follow-up was 18.2 years.
All-Cause Mortality
Cumulative survival of the 2 groups is shown in Figure 1.
In the high-GFRc group, 120 patients (45.2%) died,
whereas in the low-GFRc group, 113 patients (79.0%)
died. The variables with a significance level of P  .10
in the univariate tests were age, left ventricular function,
afting in patients, based on their calculated creatinine
2; group 2, cGFR less than 70.1 mL · min1 · 1.73 m2.ss grpreoperative diabetes mellitus, number of anastomoses,
uary 2005
van de Wal et al Surgery for Acquired Cardiovascular Disease
A
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disease, completeness of revascularization, and catego-
rized preoperative GFRc (Table 2). These values were
included in a multivariate analysis model. Multivariate
analysis identified 3 preoperative risk factors that were
related to long-term mortality: age, left ventricular func-
Table 2. Univariate hazard ratios (95% confidence interv
significant and other predictors for either total mortality o
Variable
Total
HR (95% CI)
Age (54.7 y) 2.08 (1.60-2.69)
Completeness of revascularization 1.35 (1.04-1.75)
Diabetes mellitus 2.29 (1.08-4.88)
Body mass index 1.00 (0.92-1.08)
No. of diseased vessels
Two-vessel disease 1.23 (0.79-1.91)
Three-vessel disease 1.78 (1.16-2.71)
LMCA involved 1.63 (1.13-2.35)
LV function (CASS-WMS)
8 vs. 8-10 2.02 (1.37-3.00)
8 vs. 10 3.59 (2.45-5.25)
Sex (M/F) 1.23 (0.83-1.82)
Smoking 1.17 (0.90-1.52)
Cholesterol 0.97 (0.88-1.08)
Triglycerides 1.05 (0.93-1.18)
No. of anastomoses 1.13 (1.03-1.24)
GFR (70.1 mL · min1 · 1.73 m2) 1.82 (1.41-2.36)
CI, Confidence intervals; HR, hazard ratio; LV, left ventricular; LMCA, left m
score; GFR, glomerular filtration rate.
Table 3. Multivariate hazard ratios (95% confidence inter
significant and other predictors for either total mortality o
Variable
Total
HR (95% CI)
Age (54.7 y) 1.72 (1.27-2.33)
Completeness of revascularization 1.16 (0.88-1.53)
Diabetes mellitus 2.02 (0.93-4.41)
No. of diseased vessels
Two-vessel disease 0.97 (0.59-1.60)
Three-vessel disease 1.03 (0.58-1.84)
LMCA involved 1.57 (1.08-2.29)
LV function (CASS-WMS)
8 vs. 8-10 1.68 (1.22-2.33)
8 vs. 10 2.52 (1.80-3.53)
No. of anastomoses 1.06 (0.93-1.21)
GFR (70.1 mL · min1 · 1.73 m2) 1.44 (1.06-1.96)
CI, Confidence intervals; HR, hazard ratio; LMCA, left main coronary artery
score; GFR, glomerular filtration rate.tion, and preoperative renal function (Table 3). Patients
The Journal of Thoraciin group 2 had a significantly increased risk of mortality
during follow-up (group 2 vs group 1: hazard ratio, 1.44;
95% CI 1.06-1.96; P  .019).
Cardiac Mortality
Cumulative survival of the 2 groups is shown in Figure 2. In
for total mortality and cardiac mortality of statistically
rdiac mortality
From 30 d after surgery to 18.2 y after surgery
lity Cardiac mortality
P value HR (95% CI) P value
.001 1.73 (1.26-2.38) .001
.026 1.73 (1.26-2.37) .001
.031 2.00 (0.74-554) .169
.928 0.99 (0.90-1.10) .895
.366 2.04 (1.07-3.89) .031
.008 3.03 (1.62-5.68) .001
.009 1.66 (1.07-2.59) .024
.001 1.78 (1.29-2.45) .001
.001 2.63 (1.90-3.65) .001
.311 1.25 (0.77-2.02) .365
.235 1.10 (0.79-1.51) .581
.581 1.00 (0.88-1.13) .978
.422 1.09 (0.95-1.24) .245
.013 1.20 (1.07-1.34) .001
.001 1.74 (1.27-2.39) .001
oronary artery; CASS, Coronary Artery Surgery Study; WMS, wall motion
) for total mortality and cardiac mortality of statistically
rdiac mortality
From 30 d after surgery to 18.2 y after surgery
lity Cardiac mortality
P value HR (95% CI) P value
.001 1.43 (0.99-2.08) .058
.298 1.40 (1.00-1.95) .050
.077 —
.895 1.43 (0.71-2.90) .316
.914 1.50 (0.69-3.28) .308
.020 1.53 (0.97-2.42) .070
.002 1.43 (0.71-2.90) .001
.001 3.10 (2.10-4.57) .001
.366 1.09 (0.94-1.27) .275
.019 1.51 (1.04-2.19) .032
left ventricular; CASS, Coronary Artery Surgery Study; WMS, wall motionals)
r ca
morta
ain cvalss
r ca
morta
; LV,the high-GFRc group, 83 patients (38.6%) died of cardiac
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of cardiac causes. The variables with a significance level of
P  .10 in the univariate tests were age, left ventricular
function, number of anastomoses, number of diseased ves-
sels, left main coronary artery disease, completeness of
revascularization, and preoperative GFRc (Table 2). If only
cardiac death was taken into account, categorized preoper-
ative kidney function was still a significant risk factor
(group 2 vs group 1: hazard ratio, 1.51; 95% CI 1.04-2.19;
P  .032). The 2 most powerful predictors of cardiac
mortality after multivariate analysis were left ventricular
function and preoperative kidney function (Table 3).
Myocardial Infarction and Reintervention
No significant differences were found between groups in the
occurrence of (re)myocardial infarction (group 2 vs group 1:
hazard ratio, 1.29; P  .219) or in the reintervention rate
(group 2 vs group 1: hazard ratio, 1.38; P  .198). These
data are not shown.
Discussion
In this long-term follow-up study, we demonstrated that
mild preoperative renal dysfunction is an independent pre-
dictor of long-term mortality. Ischemic heart disease is the
most common cause of death in patients with chronic kid-
ney disease,10,11 and renal dysfunction has now been gen-
erally recognized as a risk marker in a wide variety of
patients with cardiovascular disease.12 It has been well
established that patients with severe chronic renal failure
have a high risk for adverse outcome after coronary bypass
surgery.5,13,14 Several studies showed that patients with
mild renal dysfunction have an increased risk of dying
Figure 2. Cardiac mortality after coronary artery bypas
clearance: group 1, cGFR greater than 70.1 mL · min1 ·within 30 days after coronary surgery.5,13,15 Patients with
334 The Journal of Thoracic and Cardiovascular Surgery ● Febrdecreased renal function (serum creatinine 2.0 mg/dL)
carry significant operative risks, require prolonged hospital
stays, and have a higher risk of dying within 3 years after
coronary surgery.15 Nakayama and colleagues13 demon-
strated that in a group of patients with a preoperative serum
creatinine level of 1.5 mg/dL or greater (133 mol/L), the
10-year actuarial survival was significantly lower than in a
group of patients with normal serum creatinine levels (1.0
mg/dL; 88 mol/L). Most patients in our population had
a milder preoperative renal dysfunction than described in
these studies, yet this parameter was still an independent
predictor for mortality. It is interesting to note that Kaplan-
Meier analysis clearly demonstrated that differences be-
tween GFR groups occurred only after approximately 10
years of follow-up. Possibly, this mirrors an accelerated rate
of atherosclerosis, although in our population no difference
in myocardial infarction was observed between groups.
Several explanations have been proposed for the associ-
ation between renal dysfunction, cardiovascular disease,
and mortality.3,16,17 First, renal dysfunction is often associ-
ated with the presence of other cardiovascular risk factors,
such as hypertension and diabetes. In these cases, renal
dysfunction and cardiovascular morbidity would both be the
results of end-organ damage. However, the effect of renal
function on mortality in this study was independent of other
known cardiovascular risk factors. Second, renal dysfunc-
tion might be the direct effect of cardiac dysfunction. In
patients with a reduction of cardiac output, there is a decline
in renal perfusion and an activation of compensatory mech-
anisms, which leads to renal function impairment.18,19 In
these cases, renal dysfunction is a reflection of the cardiac
fting in patients, based on their calculated creatinine
2; group 2, cGFR less than 70.1 mL · min1 · 1.73 m2.s grafunction and may therefore be used as a risk marker for
uary 2005
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CDcardiovascular morbidity and mortality.20 In our patients,
this mechanism probably does not play a role, because only
a few patients had a significantly reduced left ventricular
systolic function. Finally, renal dysfunction also has a neg-
ative effect on lipids, oxidative stress, homocysteine, and
fibrinogen; this could lead to endothelial dysfunction.21
However, the question of whether endothelial dysfunction is
the connecting bond between cardiovascular risk factors and
renal dysfunction remains to be answered.
Patients receiving venous coronary bypass grafts often
need reintervention and also have a worse prognosis com-
pared with patients receiving arterial bypass grafts.22 An-
giographic and necropsy studies have found evidence of
accelerated atherosclerosis in saphenous vein conduits, pos-
sibly as a result of chronic endothelial activation.23 Nowa-
days arterial grafts are preferred to venous grafts, yet venous
conduits continue to be used in a large proportion of coro-
nary artery bypass grafting patients. Consequently, it is
important to identify all patients at risk.
Limitations
This was a post hoc analysis of prospective data. There-
fore, the results and conclusions are subject to the limi-
tations inherent to such analysis. However, the principal
variables of interest—serum creatinine and death—are
objective measures. The Cockroft-Gault equation is an
estimate of the GFR and might lead to an overestimation
of these parameters. Because this estimation was used for
all patients and because GFR was an independent predic-
tor of poor outcome, this should not affect our conclu-
sions. Furthermore, GFR is only a surrogate marker for
kidney function. In patients with an impaired GFR, no
conclusions can be drawn concerning the etiology of the
problem. Our study is also limited by a lack of data on the
progression of renal impairment during follow-up. Fi-
nally, the study is limited by the number of (mainly
white) patients participating and the fact that they were
all in the same hospital.
Conclusion
This study demonstrates that preoperative mild renal dys-
function is an important independent risk marker of long-
term survival in patients after coronary bypass surgery.
References
1. van Brussel BL, Voors AA, Ernst JM, Knaepen PJ, Plokker HW.
Venous coronary artery bypass surgery: a more than 20-year follow-up
study. Eur Heart J. 2003;24:927-36.
2. Baigent C, Burbury K, Wheeler D. Premature cardiovascular disease
in chronic renal failure. Lancet. 2000;356:147-52.
3. Jungers P, Massy ZA, Khoa TN, Fumeron C, Labrunie M, Lacour B,
et al. Incidence and risk factors of atherosclerotic cardiovascular
accidents in predialysis chronic renal failure patients: a prospective
study. Nephrol Dial Transplant. 1997;12:2597-602.
The Journal of Thoraci4. Dacey LJ, Liu JY, Braxton JH, Weintraub RM, DeSimone J, Charles-
worth DC, et al. Long-term survival of dialysis patients after coronary
bypass grafting. Ann Thorac Surg. 2002;74:458-62.
5. Anderson RJ, O’brien M, MaWhinney S, VillaNueva CB, Moritz TE,
Sethi GK, et al. Renal failure predisposes patients to adverse outcome
after coronary artery bypass surgery. VA Cooperative Study #5. Kid-
ney Int. 1999;55:1057-62.
6. van Brussel BL, Plokker HW, Ernst SM, Ernst NM, Knaepen PJ,
Koomen EM, et al. Venous coronary artery bypass surgery. A 15-year
follow-up study. Circulation. 1993;88:II87-92.
7. Wang F, Dupuis JY, Nathan H, Williams K. An analysis of the
association between preoperative renal dysfunction and outcome in
cardiac surgery: estimated creatinine clearance or plasma creatinine
level as measures of renal function. Chest. 2003;124:1852-62.
8. Voors AA, van Brussel BL, Plokker HW, Ernst SM, Ernst NM,
Koomen EM, et al. Smoking and cardiac events after venous coronary
bypass surgery. A 15-year follow-up study. Circulation. 1996;93:42-7.
9. K/DOQI clinical practice guidelines for chronic kidney disease. eval-
uation, classification, and stratification. Am J Kidney Dis. 2002;39:S1-
266.
10. Herzog CA, Ma JZ, Collins AJ. Poor long-term survival after acute
myocardial infarction among patients on long-term dialysis. N Engl
J Med. 1998;339:799-805.
11. Walsh CR, O’Donnell CJ, Camargo CA Jr, Giugliano RP, Lloyd-Jones
DM. Elevated serum creatinine is associated with 1-year mortality
after acute myocardial infarction. Am Heart J. 2002;144:1003-11.
12. Hillege HL, van Gilst WH, van Veldhuisen DJ, Navis G, Grobbee DE,
de Graeff PA, et al. Accelerated decline and prognostic impact of renal
function after myocardial infarction and the benefits of ACE inhibi-
tion: the CATS randomized trial. Eur Heart J. 2003;24:412-20.
13. Nakayama Y, Sakata R, Ura M, Itoh T. Long-term results of coronary
artery bypass grafting in patients with renal insufficiency. Ann Thorac
Surg. 2003;75:496-500.
14. Mangano CM, Diamondstone LS, Ramsay JG, Aggarwal A, Herskow-
itz A, Mangano DT. Renal dysfunction after myocardial revascular-
ization: risk factors, adverse outcomes, and hospital resource utiliza-
tion. The Multicenter Study of Perioperative Ischemia Research
Group. Ann Intern Med. 1998;128:194-203.
15. Hirose H, Amano A, Takahashi A, Nagano N. Coronary artery bypass
grafting for patients with non-dialysis-dependent renal dysfunction
(serum creatinine  or 2.0 mg/dl). Eur J Cardiothorac Surg. 2001;
20:565-72.
16. Fried LF, Shlipak MG, Crump C, Bleyer AJ, Gottdiener JS, Kronmal
RA, et al. Renal insufficiency as a predictor of cardiovascular out-
comes and mortality in elderly individuals. J Am Coll Cardiol. 2003;
41:1364-72.
17. Ritz E, Dikow R, Ruilope LM. Renal dysfunction as a cardiovascular
risk factor. Curr Hypertens Rep. 2002;4:365-8.
18. Ljungman S, Laragh JH, Cody RJ. Role of the kidney in congestive
heart failure. Relationship of cardiac index to kidney function Drugs.
1990;39(suppl 4):10-21.
19. Magri P, Rao MA, Cangianiello S, Bellizzi V, Russo R, Mele AF, et
al. Early impairment of renal hemodynamic reserve in patients with
asymptomatic heart failure is restored by angiotensin II antagonism.
Circulation. 1998;98:2849-54.
20. Hillege HL, Girbes AR, de Kam PJ, Boomsma F, de Zeeuw D,
Charlesworth A, et al. Renal function, neurohormonal activation, and
survival in patients with chronic heart failure. Circulation. 2000;102:
203-10.
21. Best PJ, Lennon R, Ting HH, Bell MR, Rihal CS, Holmes DR, et al.
The impact of renal insufficiency on clinical outcomes in patients
undergoing percutaneous coronary interventions. J Am Coll Cardiol.
2002;39:1113-9.
22. Loop FD, Lytle BW, Cosgrove DM, Stewart RW, Goormastic M, Wil-
liams GW, et al. Influence of the internal-mammary-artery graft on
10-year survival and other cardiac events. N Engl J Med. 1986;314:1-6.
23. Motwani JG, Topol EJ. Aortocoronary saphenous vein graft disease:
pathogenesis, predisposition, and prevention. Circulation. 1998;97:
916-31.
c and Cardiovascular Surgery ● Volume 129, Number 2 335
